Abstract
An enzyme-linked immunosorbent assay (ELISA) using a synthetic peptide for the E2 glycoprotein was developed for the serodiagnosis of Getah virus infection in horses. To identify an immunogenic epitope, a series of 20-mer peptides (n = 22) for the E2 protein was screened with pooled sera from horses infected with Getah virus. Peptide P11 (PTEEEIDMHTPPDIPDITLL) showed the strongest reaction. ELISA using P11 (E2-P11-ELISA) detected increased antibody levels in all seven experimentally infected horses and in five out of nine vaccinated horses. Out of 28 naturally infected horses, 25 were seronegative in their acute sera but turned seropositive in their convalescent sera. For the remaining three horses whose acute sera were seropositive, an endpoint method with serial dilutions detected a ≥ 4-fold increase in titer between paired sera. The concordance between E2-P11-ELISA and a virus-neutralization test in terms of seropositivity was assessed using a series of 220 horse sera, resulting in almost perfect agreement, with a kappa coefficient value of 0.865. E2-P11-ELISA had a sensitivity of 93.3% (95% CI 86.6–97.1%) and a specificity of 95.0% (95% CI 92.5–96.4%). This highly sensitive and specific E2-P11-ELISA should be useful for serodiagnosis of Getah virus infection in horses.
Similar content being viewed by others
Data availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Bannai H, Nemoto M, Ochi A, Kikuchi T, Kobayashi M, Tsujimura K, Yamanaka T, Kondo T (2015) Epizootiological investigation of Getah virus infection among racehorses in Japan in 2014. J Clin Microbiol 53:2286–2291
Bannai H, Nemoto M, Tsujimura K, Yamanaka T, Kokado H (2019) Development of an enzyme-linked immunosorbent assay for Getah virus infection in horses using recombinant E2 protein as an antigen. J Virol Methods 271:113681
Bannai H, Ochi A, Nemoto M, Tsujimura K, Yamanaka T, Kondo T (2016) A 2015 outbreak of Getah virus infection occurring among Japanese racehorses sequentially to an outbreak in 2014 at the same site. BMC Vet Res 12:98
Cho B, Jeon B, Kim J, Noh J, Kim J, Park M, Park S (2008) Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection. Yonsei Med J 49:828–835
Fong RH, Banik SSR, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajar S, Srinivasan S, Mabila M, Miller A, Muench MO, Michault A, Rucker JB, Paes C, Simmons G, Kahle KM, Doranz BJ (2014) Exposure of epitope residues on the outer face of the Chikungunya virus envelope trimer determines antibody neutralizing efficacy. J Virol 88:14364–14379
Fukunaga Y, Kumanomido T, Kamada M (2000) Getah virus as an equine pathogen. Vet Clin N Am Equine Pract 16:605–617
Imagawa H, Fukunaga Y, Kamada M (1992) Development of SN, HI and CF antibodies in infected horses with Getah virus. Bull Equine Res Inst 29:32–35
Izumida A, Takuma H, Inagaki S, Kubota M, Hirahara T, Kodama K, Sasaki N (1988) Experimental infection of Getah virus in swine. Jpn J Vet Sci 50:679–684
Kamada M, Ando Y, Fukunaga Y, Kumanomido T, Imagawa H, Wada R, Akiyama Y (1980) Equine Getah virus infection: isolation of the virus from racehorses during an enzootic in Japan. Am J Trop Med Hyg 29:984–988
Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174
Li L, Jose J, Xiang Y, Kuhn RJ, Rossmann MG (2010) Structural changes of envelope proteins during alphavirus fusion. Nature 468:705–708
Morey SH, Kashyap RS, Purohit HJ, Taori GM, Daginawala HF (2010) An approach towards peptide-based antibody detection for diagnosis of Chikungunya infection. Biomarkers 15:546–552
Nemoto M, Bannai H, Ochi A, Niwa H, Murakami S, Tsujimura K, Yamanaka T, Kokado H, Kondo T (2017) Complete genome sequences of Getah virus strains isolated from horses in 2016 in Japan. Genome Announc 5:e00750-17
Nemoto M, Bannai H, Tsujimura K, Kobayashi M, Kikuchi T, Yamanaka T, Kondo T (2015) Getah virus infection among racehorses, Japan, 2014. Emerg Infect Dis 21:883–885
Nemoto M, Bannai H, Tsujimura K, Yamanaka T, Kondo T (2016) Genomic, pathogenic, and antigenic comparisons of Getah virus strains isolated in 1978 and 2014 in Japan. Arch Virol 161:1691–1695
Verma P, Bhatnagar S, Kumar P, Chattree V, Parida MM, Hoti SL, Ali S, Rao DN (2014) Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using a panel of peptides derived from envelope protein for serodiagnosis. Clin Chem Lab Med 52:297–307
Voss JE, Vaney MC, Duquerroy S, Vonrhein C, Girard-Blanc C, Crublet E, Thompson A, Bricogne G, Rey FA (2010) Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography. Nature 468:709–712
Weger-Lucarelli J, Aliota MT, Wlodarchak N, Kamlangdee A, Swanson R, Osorio JE (2016) Dissecting the role of E2 protein domains in Alphavirus pathogenicity. J Virol 90:2418–2433
Yago K, Hagiwara S, Kawamura H, Narita M (1987) A fatal case in newborn piglets with Getah virus infection: isolation of the virus. Jpn J Vet Sci 49:989–994
Acknowledgements
We thank Akira Kokubun, Akiko Kasagawa, Akiko Suganuma, Kaoru Watanabe, and Kaoru Makabe of the Equine Research Institute for their technical assistance.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Handling Editor: Patricia Aguilar.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Bannai, H., Nemoto, M., Tsujimura, K. et al. Establishment of an enzyme-linked immunosorbent assay for Getah virus infection in horses using a 20-mer synthetic peptide for the E2 glycoprotein as an antigen. Arch Virol 165, 377–385 (2020). https://doi.org/10.1007/s00705-019-04508-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-019-04508-2